3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
Cyclophosphamide
27
fludarabine phosphate
19
Whole-Body Irradiation
18
Peripheral Blood Stem Cell Transplantation
18
Etoposide
17
Rituximab
15
Brentuximab Vedotin
15
Mycophenolic Acid
14
Tacrolimus
13
Doxorubicin
12
Vincristine
11
Prednisone
11
Methotrexate
11
Busulfan
11
Melphalan
9
Antilymphocyte Serum
9
Cyclosporine
8
Filgrastim
6
Carboplatin
6
Sirolimus
5
Radiotherapy
5
Lenalidomide
5
Gene Expression Profiling
5
Cytarabine
5
merphos
4
Vorinostat
4
Immunohistochemistry
4
Ifosfamide
4
Gemcitabine
4
Flow Cytometry
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large-Cell, Anaplastic
×
entinostat
×
Clear all
No trials found.